{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "31953420", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "17"}], "Language": ["eng"], "ELocationID": ["625", "10.1038/s41598-019-57192-2"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Jan", "Day": "17"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.", "Pagination": {"StartPage": "625", "MedlinePgn": "625"}, "Abstract": {"AbstractText": ["Chemotherapy often induces oral ulcerative mucositis (OUM) in patients with cancer, characterized by severe painful inflammation. Mouth-washing with the Japanese herbal medicine hangeshashinto (HST) ameliorates chemotherapy-induced OUM in patients with colorectal cancer. Previously, we demonstrated that HST decreased interleukin 1\u03b2-induced prostaglandin E2 production in human oral keratinocytes (HOKs) and OUM-induced mechanical or spontaneous pain in rats. However, HST effects on tissue repair functions in HOKs remain unclear. Here, we examined the effects of HST on scratch-induced wound healing in vitro and in vivo. In vitro, HST enhanced wound healing mainly through scratch-induced HOK migration. Screening of the seven constituent medicinal herbs and their major components revealed that Scutellaria root, processed ginger, and Glycyrrhiza components mainly induced the scratch-induced HOK migration. Pharmacokinetic analyses indicated that the active ingredient concentrations in rat plasma following oral HST administration were below the effective doses for HOK migration, suggesting direct effects of HST in OUM. Mitogen-activated protein kinase and C-X-C chemokine receptor 4 inhibitors significantly suppressed HST-induced HOK migration. Moreover, HST enhanced tissue repair in our OUM rat model. Thus, HST likely enhanced OUM tissue repair through oral keratinocyte migration upon MAPK and CXCR4 activation and may be useful in patients with cancer-associated OUM."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}], "LastName": "Miyano", "ForeName": "Kanako", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}, {"Identifier": [], "Affiliation": "Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, 278-8510, Japan."}], "LastName": "Eto", "ForeName": "Moeko", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Physiology, Kyushu Dental University, Fukuoka, 803-8580, Japan."}], "LastName": "Hitomi", "ForeName": "Suzuro", "Initials": "S"}, {"Identifier": ["0000-0003-2653-5372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan."}], "LastName": "Matsumoto", "ForeName": "Takashi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan."}], "LastName": "Hasegawa", "ForeName": "Seiya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan."}], "LastName": "Hirano", "ForeName": "Ayane", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan."}], "LastName": "Nagabuchi", "ForeName": "Kaori", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan."}], "LastName": "Asai", "ForeName": "Noriho", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}], "LastName": "Uzu", "ForeName": "Miaki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan."}], "LastName": "Nonaka", "ForeName": "Miki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan."}], "LastName": "Omiya", "ForeName": "Yuji", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Tsumura Kampo Research Laboratories, Tsumura & Co., Ibaraki, 300-1192, Japan."}], "LastName": "Kaneko", "ForeName": "Atsushi", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Physiology, Kyushu Dental University, Fukuoka, 803-8580, Japan."}], "LastName": "Ono", "ForeName": "Kentaro", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan."}], "LastName": "Fujii", "ForeName": "Hideaki", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, 278-8510, Japan."}, {"Identifier": [], "Affiliation": "Translational Research Center, Research Institute of Science and Technology, Tokyo University of Science, Chiba, 278-8510, Japan."}], "LastName": "Higami", "ForeName": "Yoshikazu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Clinical and Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan."}], "LastName": "Kono", "ForeName": "Toru", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp."}, {"Identifier": [], "Affiliation": "Division of Supportive Care Research, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp."}, {"Identifier": [], "Affiliation": "Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Tokyo, 104-0045, Japan. yuezono@ncc.go.jp."}], "LastName": "Uezono", "ForeName": "Yasuhito", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "CXCR4 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, CXCR4"}, {"RegistryNumber": "0", "NameOfSubstance": "hange-shashinto"}, {"RegistryNumber": "EC 2.7.12.2", "NameOfSubstance": "Mitogen-Activated Protein Kinase Kinases"}], "CommentsCorrectionsList": [{"RefSource": "Sci Rep. 2020 Nov 9;10(1):19806. doi: 10.1038/s41598-020-76581-6", "PMID": "33168924"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["administration & dosage", "chemistry", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Zingiber officinale"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Keratinocytes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinase Kinases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, CXCR4"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Stomatitis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Wound Healing"}], "CoiStatement": "Y.U. and K.M. received grant support from the Japan Agency for Medical Research and Development (AMED). K.O., T.K. and Y.U. received grant support from Tsumura & Co. T.M., Y.O. and A.K. are employees of Tsumura & Co. Other authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "McGuire DB, et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncology nursing forum. 1993;20:1493\u20131502.", "ArticleIdList": ["8278277"]}, {"Citation": "Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral oncology. 1998;34:39\u201343. doi: 10.1016/S1368-8375(97)00053-5.", "ArticleIdList": ["10.1016/S1368-8375(97)00053-5", "9659518"]}, {"Citation": "Dodd MJ, et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2000;90:39\u201347. doi: 10.1067/moe.2000.105713.", "ArticleIdList": ["10.1067/moe.2000.105713", "10884634"]}, {"Citation": "Dorr W, Hamilton CS, Boyd T, Reed B, Denham JW. Radiation-induced changes in cellularity and proliferation in human oral mucosa. International journal of radiation oncology, biology, physics. 2002;52:911\u2013917. doi: 10.1016/S0360-3016(01)02721-3.", "ArticleIdList": ["10.1016/S0360-3016(01)02721-3", "11958883"]}, {"Citation": "Sonis ST. Pathobiology of mucositis. Seminars in oncology nursing. 2004;20:11\u201315. doi: 10.1053/j.soncn.2003.10.003.", "ArticleIdList": ["10.1053/j.soncn.2003.10.003", "15038512"]}, {"Citation": "Duncan GG, et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head & neck. 2005;27:421\u2013428. doi: 10.1002/hed.20162.", "ArticleIdList": ["10.1002/hed.20162", "15782422"]}, {"Citation": "Jones JA, et al. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2006;14:505\u2013515. doi: 10.1007/s00520-006-0055-4.", "ArticleIdList": ["10.1007/s00520-006-0055-4", "16601950"]}, {"Citation": "Vera-Llonch M, Oster G, Hagiwara M, Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer. 2006;106:329\u2013336. doi: 10.1002/cncr.21622.", "ArticleIdList": ["10.1002/cncr.21622", "16342066"]}, {"Citation": "Barber C, Powell R, Ellis A, Hewett J. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2007;15:427\u2013440. doi: 10.1007/s00520-006-0171-1.", "ArticleIdList": ["10.1007/s00520-006-0171-1", "17131132"]}, {"Citation": "El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA. The effectiveness of vitamin \u201cE\u201d in the treatment of oral mucositis in children receiving chemotherapy. The Journal of clinical pediatric dentistry. 2007;31:167\u2013170. doi: 10.17796/jcpd.31.3.r8371x45m42l10j7.", "ArticleIdList": ["10.17796/jcpd.31.3.r8371x45m42l10j7", "17550040"]}, {"Citation": "Vera-Llonch M, Oster G, Ford CM, Lu J, Sonis S. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. The journal of supportive oncology. 2007;5:231\u2013235.", "ArticleIdList": ["17564153"]}, {"Citation": "Bensinger, W. et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. Journal of the National Comprehensive Cancer Network: JNCCN6 Suppl 1, S1\u201321; quiz S22\u201324 (2008).", "ArticleIdList": ["18289497"]}, {"Citation": "Sonis ST. Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core evidence. 2010;4:199\u2013205.", "ArticleIdList": ["PMC2899789", "20694076"]}, {"Citation": "Sonis ST. New thoughts on the initiation of mucositis. Oral diseases. 2010;16:597\u2013600. doi: 10.1111/j.1601-0825.2010.01681.x.", "ArticleIdList": ["10.1111/j.1601-0825.2010.01681.x", "20846150"]}, {"Citation": "Miyano K, Ueno T, Yatsuoka W, Uezono Y. Treatment for Cancer Patients with Oral Mucositis: Assessment Based on the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer in International Society of Oral Oncology (MASCC/ISOO) in 2013 and Proposal of Possible Novel Treatment with a Japanese Herbal Medicine. Current pharmaceutical design. 2016;22:2270\u20132278. doi: 10.2174/1381612822666160219120842.", "ArticleIdList": ["10.2174/1381612822666160219120842", "26891806"]}, {"Citation": "Elting LS, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98:1531\u20131539. doi: 10.1002/cncr.11671.", "ArticleIdList": ["10.1002/cncr.11671", "14508842"]}, {"Citation": "Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. International journal of radiation oncology, biology, physics. 2007;68:1110\u20131120. doi: 10.1016/j.ijrobp.2007.01.053.", "ArticleIdList": ["10.1016/j.ijrobp.2007.01.053", "17398022"]}, {"Citation": "Yeoh AS, et al. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Molecular cancer therapeutics. 2007;6:2319\u20132327. doi: 10.1158/1535-7163.Mct-07-0113.", "ArticleIdList": ["10.1158/1535-7163.Mct-07-0113", "17699727"]}, {"Citation": "Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120:1453\u20131461. doi: 10.1002/cncr.28592.", "ArticleIdList": ["10.1002/cncr.28592", "PMC4164022", "24615748"]}, {"Citation": "Trotti A, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 2003;66:253\u2013262. doi: 10.1016/S0167-8140(02)00404-8.", "ArticleIdList": ["10.1016/S0167-8140(02)00404-8", "12742264"]}, {"Citation": "Uezono Y, et al. A review of traditional Japanese medicines and their potential mechanism of action. Current pharmaceutical design. 2012;18:4839\u20134853. doi: 10.2174/138161212803216924.", "ArticleIdList": ["10.2174/138161212803216924", "22632864"]}, {"Citation": "Matsuda C, et al. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis. Cancer chemotherapy and pharmacology. 2015;76:97\u2013103. doi: 10.1007/s00280-015-2767-y.", "ArticleIdList": ["10.1007/s00280-015-2767-y", "PMC4485889", "25983022"]}, {"Citation": "Fukamachi H, et al. Effects of Hangeshashinto on Growth of Oral Microorganisms. Evidence-based complementary and alternative medicine: eCAM. 2015;2015:512947. doi: 10.1155/2015/512947.", "ArticleIdList": ["10.1155/2015/512947", "PMC4485921", "26170876"]}, {"Citation": "Matsumoto C, et al. Analysis of the antioxidative function of the radioprotective Japanese traditional (Kampo) medicine, hangeshashinto, in an aqueous phase. Journal of radiation research. 2015;56:669\u2013677. doi: 10.1093/jrr/rrv023.", "ArticleIdList": ["10.1093/jrr/rrv023", "PMC4497396", "25883171"]}, {"Citation": "Hiroshima Y, et al. Effect of Hangeshashinto on calprotectin expression in human oral epithelial cells. Odontology. 2016;104:152\u2013162. doi: 10.1007/s10266-015-0196-3.", "ArticleIdList": ["10.1007/s10266-015-0196-3", "25649126"]}, {"Citation": "Kono T, et al. Multitargeted Effects of Hangeshashinto for Treatment of Chemotherapy-Induced Oral Mucositis on Inducible Prostaglandin E2 Production in Human Oral Keratinocytes. Integrative Cancer Therapies. 2014;13:435\u2013445. doi: 10.1177/1534735413520035.", "ArticleIdList": ["10.1177/1534735413520035", "24501112"]}, {"Citation": "Hitomi S, et al. The traditional Japanese medicine hangeshashinto alleviates oral ulcer-induced pain in a rat model. Archives of oral biology. 2016;66:30\u201337. doi: 10.1016/j.archoralbio.2016.02.002.", "ArticleIdList": ["10.1016/j.archoralbio.2016.02.002", "26878477"]}, {"Citation": "Hitomi S, et al. [6]-gingerol and [6]-shogaol, active ingredients of the traditional Japanese medicine hangeshashinto, relief oral ulcerative mucositis-induced pain via action on Na(+) channels. Pharmacological research. 2017;117:288\u2013302. doi: 10.1016/j.phrs.2016.12.026.", "ArticleIdList": ["10.1016/j.phrs.2016.12.026", "28043879"]}, {"Citation": "Yonezawa A, Hori T, Sakaida H, Uchiyama T. SDF-1 has costimulatory effects on human T cells: possible involvement of MAPK (ERK2) activation. Microbiology and immunology. 2000;44:135\u2013141. doi: 10.1111/j.1348-0421.2000.tb01256.x.", "ArticleIdList": ["10.1111/j.1348-0421.2000.tb01256.x", "10803500"]}, {"Citation": "Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. The Journal of biological chemistry. 2002;277:49212\u201349219. doi: 10.1074/jbc.M207294200.", "ArticleIdList": ["10.1074/jbc.M207294200", "12370187"]}, {"Citation": "Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer research. 2005;65:9891\u20139898. doi: 10.1158/0008-5472.Can-05-1293.", "ArticleIdList": ["10.1158/0008-5472.Can-05-1293", "16267013"]}, {"Citation": "Chao JI, Su WC, Liu HF. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Molecular cancer therapeutics. 2007;6:3039\u20133048. doi: 10.1158/1535-7163.Mct-07-0281.", "ArticleIdList": ["10.1158/1535-7163.Mct-07-0281", "18025287"]}, {"Citation": "Kanda N, Shimizu T, Tada Y, Watanabe S. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes. European journal of immunology. 2007;37:338\u2013350. doi: 10.1002/eji.200636420.", "ArticleIdList": ["10.1002/eji.200636420", "17274000"]}, {"Citation": "Kanda N, Watanabe S. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology. 2007;148:2317\u20132325. doi: 10.1210/en.2006-1639.", "ArticleIdList": ["10.1210/en.2006-1639", "17255201"]}, {"Citation": "Gaundar SS, Bradstock KF, Bendall LJ. p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells. Cell cycle (Georgetown, Tex.) 2009;8:2975\u20132983. doi: 10.4161/cc.8.18.9545.", "ArticleIdList": ["10.4161/cc.8.18.9545", "19713744"]}, {"Citation": "Huang CY, et al. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways. Journal of cellular physiology. 2009;221:204\u2013212. doi: 10.1002/jcp.21846.", "ArticleIdList": ["10.1002/jcp.21846", "19496172"]}, {"Citation": "Kim JH, et al. [6]-Gingerol suppresses interleukin-1 beta-induced MUC5AC gene expression in human airway epithelial cells. American journal of rhinology & allergy. 2009;23:385\u2013391. doi: 10.2500/ajra.2009.23.3337.", "ArticleIdList": ["10.2500/ajra.2009.23.3337", "19671252"]}, {"Citation": "Yuan L, Sakamoto N, Song G, Sato M. Low-level shear stress induces human mesenchymal stem cell migration through the SDF-1/CXCR4 axis via MAPK signaling pathways. Stem cells and development. 2013;22:2384\u20132393. doi: 10.1089/scd.2012.0717.", "ArticleIdList": ["10.1089/scd.2012.0717", "23544621"]}, {"Citation": "Kim SM, et al. 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways. Molecular carcinogenesis. 2015;54:1132\u20131146. doi: 10.1002/mc.22184.", "ArticleIdList": ["10.1002/mc.22184", "24962868"]}, {"Citation": "Ryu MJ, Chung HS. [10]-Gingerol induces mitochondrial apoptosis through activation of MAPK pathway in HCT116 human colon cancer cells. In vitro cellular & developmental biology. Animal. 2015;51:92\u2013101. doi: 10.1007/s11626-014-9806-6.", "ArticleIdList": ["10.1007/s11626-014-9806-6", "25148824"]}, {"Citation": "Cui C, et al. Sulfated polysaccharide isolated from the sea cucumber Stichopus japonicas promotes the SDF-1alpha/CXCR4 axis-induced NSC migration via the PI3K/Akt/FOXO3a, ERK/MAPK, and NF-kappaB signaling pathways. Neuroscience letters. 2016;616:57\u201364. doi: 10.1016/j.neulet.2016.01.041.", "ArticleIdList": ["10.1016/j.neulet.2016.01.041", "26827717"]}, {"Citation": "Su MQ, et al. Baicalein induces the apoptosis of HCT116 human colon cancer cells via the upregulation of DEPP/Gadd45a and activation of MAPKs. International journal of oncology. 2018;53:750\u2013760. doi: 10.3892/ijo.2018.4402.", "ArticleIdList": ["10.3892/ijo.2018.4402", "29749481"]}, {"Citation": "Miyashita, T. et al. Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer. Surgery, 10.1016/j.surg.2018.02.003 (2018).", "ArticleIdList": ["29576309"]}, {"Citation": "Kono T, et al. Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis. World journal of oncology. 2010;1:232\u2013235. doi: 10.4021/wjon263w.", "ArticleIdList": ["10.4021/wjon263w", "PMC5649748", "29147213"]}, {"Citation": "Rosen LS. Irinotecan in lymphoma, leukemia, and breast, pancreatic, ovarian, and small-cell lung cancers. Oncology (Williston Park, N.Y.) 1998;12:103\u2013109.", "ArticleIdList": ["9726101"]}, {"Citation": "Abigerges D, et al. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1995;13:210\u2013221. doi: 10.1200/jco.1995.13.1.210.", "ArticleIdList": ["10.1200/jco.1995.13.1.210", "7799022"]}, {"Citation": "Hecht JR. Gastrointestinal toxicity or irinotecan. Oncology (Williston Park, N.Y.) 1998;12:72\u201378.", "ArticleIdList": ["9726096"]}, {"Citation": "Takasuna K, et al. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Japanese journal of cancer research: Gann. 1995;86:978\u2013984. doi: 10.1111/j.1349-7006.1995.tb03010.x.", "ArticleIdList": ["10.1111/j.1349-7006.1995.tb03010.x", "PMC5920598", "7493918"]}, {"Citation": "Mori K, Kondo T, Kamiyama Y, Kano Y, Tominaga K. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Cancer chemotherapy and pharmacology. 2003;51:403\u2013406. doi: 10.1007/s00280-003-0585-0.", "ArticleIdList": ["10.1007/s00280-003-0585-0", "12687289"]}, {"Citation": "Yamaguchi K, et al. Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil. Pain. 2016;157:1004\u20131020. doi: 10.1097/j.pain.0000000000000498.", "ArticleIdList": ["10.1097/j.pain.0000000000000498", "26808144"]}, {"Citation": "Parkins CS, Fowler JF, Yu S. A murine model of lip epidermal/mucosal reactions to X-irradiation. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology. 1983;1:159\u2013165. doi: 10.1016/S0167-8140(83)80018-8.", "ArticleIdList": ["10.1016/S0167-8140(83)80018-8", "6680220"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "7", "Day": "16"}, {"Year": "2019", "Month": "12", "Day": "19"}, {"Year": "2020", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["31953420", "PMC6969174", "10.1038/s41598-019-57192-2", "10.1038/s41598-019-57192-2"]}}], "PubmedBookArticle": []}